Weiguo Su
Impact in
- Hepatology top 10%
- Liver physiology and pathology
- Oncology top 10%
- Colorectal Cancer Treatments and Studies
- Lung Cancer Research Studies
Papers in
- Oncology 33
- Colorectal Cancer Treatments and Studies 14
- Lung Cancer Research Studies 7
-
- Lung Cancer Treatments and Mutations 19
- Gastric Cancer Management and Outcomes 8
- Co-authors
- Yang Sai (11 shared papers)Yongxin Ren (18 shared papers)Songhua Fan (12 shared papers)Yi Gu (6 shared papers)Weiguo Qing (14 shared papers)Jinghong Zhou (8 shared papers)Junning Cao (4 shared papers)Jian Wang (2 shared papers)
- Journals
- Journal of Clinical Oncology (18 papers)Cancer Research (10 papers)Annals of Oncology (5 papers)Frontiers in Pharmacology (2 papers)Molecular Cancer Therapeutics (2 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Weiguo Su
63 papers receiving 731 citations
Peers
Comparison fields: 5 of 69
- Hepatology 101
- Oncology 303
- Pulmonary and Respiratory Medicine 269
- Pathology and Forensic Medicine 91
- Genetics 47
Countries citing papers authored by Weiguo Su
This map shows the geographic impact of Weiguo Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiguo Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiguo Su more than expected).
Fields of papers citing papers by Weiguo Su
This network shows the impact of papers produced by Weiguo Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiguo Su. The network helps show where Weiguo Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Weiguo Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 68 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 117 | |
| 2 | 2017 | 69 | |
| 3 | 2016 | 50 | |
| 4 | 2020 | 49 | |
| 5 | 2019 | 44 | |
| 6 | 2014 | 40 | |
| 7 | 2022 | 34 | |
| 8 | 2020 | 30 | |
| 9 | 2016 | 27 | |
| 10 | 2018 | 24 | |
| 11 | 2021 | 22 | |
| 12 | 2021 | 19 | |
| 13 | 2019 | 16 | |
| 14 | 2019 | 15 | |
| 15 | 2014 | 14 | |
| 16 | 2021 | 10 | |
| 17 | 2015 | 10 | |
| 18 | 2022 | 10 | |
| 19 | 2017 | 9 | |
| 20 | 2024 | 9 |
About Weiguo Su
Weiguo Su is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Genetics and Hepatology, having authored 68 papers that have together received 742 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (19 papers), Colorectal Cancer Treatments and Studies (14 papers), Chronic Lymphocytic Leukemia Research (10 papers), Liver physiology and pathology (9 papers), Gastric Cancer Management and Outcomes (8 papers), Lung Cancer Research Studies (7 papers), PI3K/AKT/mTOR signaling in cancer (6 papers) and Neuroendocrine Tumor Research Advances (5 papers). The work is most often cited by research in Hepatology (101 citations), Oncology (303 citations), Pulmonary and Respiratory Medicine (269 citations), Pathology and Forensic Medicine (91 citations) and Genetics (47 citations). Weiguo Su has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Yang Sai, Yongxin Ren, Songhua Fan, Yi Gu, Weiguo Qing, Jinghong Zhou, Junning Cao, Jian Wang, Shiming Fan and Guangxiu Dai. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Annals of Oncology, Frontiers in Pharmacology and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.